Rankings
▼
Calendar
FATE FY 2013 Earnings — Fate Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FATE
Fate Therapeutics, Inc.
$143M
FY 2013 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$971,000
-63.6% YoY
Gross Profit
-$11M
-1136.6% margin
Operating Income
-$18M
-1820.3% margin
Net Income
-$21M
-2151.8% margin
EPS (Diluted)
$-1.06
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$16M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$56M
Total Liabilities
$5M
Stockholders' Equity
$51M
Cash & Equivalents
$54M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$971,000
$3M
-63.6%
Gross Profit
-$11M
-$9M
-18.3%
Operating Income
-$18M
-$14M
-30.4%
Net Income
-$21M
-$14M
-46.7%
← FY 2012
All Quarters
FY 2014 →